# Regulatory Updates Powered by Good Face: April 2026 Edition We're pleased to share the April 2026 edition of our Regulatory Recap, powered by Good Face. Our system has been updated with the most recent regulatory developments across key markets — including new PFAS legislation in New Jersey, updates to Canada's fragrance allergen labeling requirements and Environmental Protection Act, revised cosmetic safety standards in China, and inventory updates in Australia. This edition also highlights new retailer restricted substance lists and the addition of the IFRA Annex of Contributions as a standalone policy. Keep reading to explore these updates in detail. ### United States – New Jersey Protecting Against Forever Chemicals Act (S1042) The New Jersey Protecting Against Forever Chemicals Act (S1042) was signed into law on January 12, 2026, making New Jersey one of the most restrictive U.S. states on PFAS in consumer products. The law prohibits the sale, offer for sale, or distribution of cosmetics, carpets, fabric treatments, and food packaging containing intentionally added PFAS, effective January 12, 2028. PFAS are defined under the Act as fluorinated organic chemicals containing at least one fully fluorinated carbon atom, and the prohibition applies whether PFAS are added for direct functionality or generate PFAS degradation byproducts. Notably, the law does not exempt fluoropolymers, and applies exclusively to intentionally added PFAS — products where PFAS contamination occurs as a technically unavoidable trace from manufacturing are not covered. Cosmetics manufacturers selling into New Jersey should begin formulation audits now to identify any PFAS-containing ingredients and assess their reformulation pathway ahead of the 2028 enforcement date. ### Canadian Environmental Protection Act (CEPA) A Ministerial Condition was issued for Siloxanes and Silicones, di-Me, Me 3,3,3-trifluoropropyl (CAS 3088114-77-1), permitting its manufacture or import subject to strict handling, disposal, transfer, and record-keeping obligations. Additionally, Cyclohexylamine and Ethylhexyl Ethylhexanoate have been made subject to Significant New Activity (SNAc) requirements, meaning any new use of these substances must be assessed before commencement. The Domestic Substances List (DSL) has also been updated with a new January 28, 2026 version adding new ingredients, and Phenol, methylstyrenated has received its own regulatory action. These updates reflect Canada's ongoing commitment to proactive chemical risk management under CEPA, and cosmetic formulators should verify whether any of these substances appear in their formulations, particularly if new applications are being considered. The full regulatory notices can be found [here](https://gazette.gc.ca/rp-pr/p1/2026/2026-02-07/pdf/g1-16006.pdf#page=3), [here](https://gazette.gc.ca/rp-pr/p2/2026/2026-02-25/html/sor-dors26-eng.html) and [here](https://gazette.gc.ca/rp-pr/p1/2026/2026-03-14/pdf/g1-16011.pdf#page=3). ### Canada Cosmetic Ingredient Standard Canada has implemented new fragrance allergen labeling requirements under its Cosmetic Regulations (SOR/2024-63), with the first compliance deadline now in effect. As of April 12, 2026, all cosmetic products — new and existing — must disclose 24 specific fragrance allergens on product labels when present above threshold concentrations: 0.001% in leave-on products and 0.01% in rinse-off products. These allergens must be listed individually within the ingredient list, outside of the term "parfum." The list mirrors the core fragrance allergens in Annex III of the EU Cosmetic Products Regulation, bringing Canada into closer alignment with European standards. A second deadline follows on August 1, 2026, at which point newly introduced cosmetics must disclose the full expanded list of 81 fragrance allergens. Existing products will have until August 1, 2028 to comply with the expanded list. Health Canada has indicated it will take a compliance-promotion approach during the first year following the April 12, 2026 deadline, with full enforcement beginning April 12, 2027. ### China Cosmetic Safety Standard On January 12, 2026, China's National Medical Products Administration (NMPA) issued Announcement No. 6 of 2026, incorporating 18 new and revised standards into the Cosmetic Safety Technical Standards (STSC 2015), following a public consultation concluded in September 2025. All of the changes introduced by this announcement will take effect on January 1, 2027, and include: stricter total bacterial count limits for eye cosmetics, lip cosmetics, and children's cosmetics; a reduction in the permitted residual level of 1,4-Dioxane in finished products from 30 ppm to 10 ppm; the official ban of the UV filter 4-Methylbenzylidene Camphor (4-MBC), aligning China with EU regulations; new technical concentration standards for 6-Amino-m-Cresol; and the ban of Perfluorooctyl Sulfonic Acid and its salts (PFOS). A further set of changes is scheduled to enter into force on January 1, 2028, and manufacturers should monitor the NMPA for further guidance. ### Australian Inventory of Industrial Chemicals (AIIC) The Australian Inventory of Industrial Chemicals (AIIC) has been updated with the addition of a new substance: 2-Butenedioic acid (2Z)-, polymer with 2-methoxyethylene, calcium zinc salt (CAS 133222-51-2). This substance was added to the inventory five years after the issuance of its assessment certificate, in accordance with Section 82 of the Industrial Chemicals Act 2019. Listing on the AIIC means the substance may now be introduced by any registered importer or manufacturer in Australia, subject to the terms of the inventory listing and applicable record-keeping requirements. ### Australia – TGA Permissible Ingredients Database (PID) The Australia – TGA Permissible Ingredients Database (PID) was updated in Good Face to reflect the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026, which commenced on 1 March 2026. This routine update modifies requirements for 22 listed medicine ingredients. The full determination can be found [here](https://www.tga.gov.au/news/regulatory-decision-notices/update-listed-medicine-ingredients-march-2026). ### Goop Clean Beauty The Goop Clean Beauty policy has been added to the Good Face system as of March 2026. This policy reflects the ingredient standards and prohibited substance requirements upheld by Goop's clean beauty program, enabling brands to efficiently assess formulation compliance against Goop's criteria. ### Made in Alignment The Made in Alignment Restricted Substances List has been added to the Good Face system as of March 2026. This policy outlines the ingredient restrictions and prohibited substance commitments upheld by the Made in Alignment initiative, providing manufacturers with a clear reference for formulation compliance aligned with this retailer's standards. ### Natural Grocers - Restricted Substances List The Natural Grocers Restricted Substances List has been added to the Good Face system as of March 2026. This list reflects the retailer's ingredient standards and prohibited substance requirements for products sold in their stores, enabling brands to efficiently assess formulation compliance against Natural Grocers' criteria. ### IFRA Annex on Contributions The IFRA Annex of Contributions has been added as a standalone policy. The Annex of Contributions documents the individual fragrance ingredient entries that underpin the IFRA Standard's usage limits and restrictions, providing an additional layer of granularity for formulators assessing fragrance compliance. This addition supports more detailed regulatory analysis for brands subject to IFRA compliance requirements.